LINC01257 and acute myeloid leukemia: To further assess the potential of LINC01257 as an AML-specific therapeutic target, we explored whether LINC01257 is specifically found in t(8;21)-translocated AML patients and whether it is differentially expressed in these cells when compared to healthy hematopoietic cells.